Français
ItalianoBond Eli Lilly 5.95% ( US532457BC13 ) in USD
| Issuer | Eli Lilly | ||||||||||||||||||||||||
| Market price |  111.246 % ▲ |
||||||||||||||||||||||||
| Country |  United States
|
||||||||||||||||||||||||
| ISIN code |
 US532457BC13 ( in USD )
|
||||||||||||||||||||||||
| Interest rate | 5.95% per year ( payment 2 times a year) | ||||||||||||||||||||||||
| Maturity | 11/15/2037 | ||||||||||||||||||||||||
| Minimal amount | 1 000 USD | ||||||||||||||||||||||||
| Total amount | 400 000 000 USD | ||||||||||||||||||||||||
| Cusip | 532457BC1 | ||||||||||||||||||||||||
| Standard & Poor's ( S&P ) rating | A+ ( Upper medium grade - Investment-grade ) | ||||||||||||||||||||||||
| Moody's rating | Aa3 ( High grade - Investment-grade ) | ||||||||||||||||||||||||
| Next Coupon | 11/15/2026 ( Today ) | ||||||||||||||||||||||||
| Detailed description |
Eli Lilly and Company is a global pharmaceutical company specializing in the research, development, manufacturing, and marketing of pharmaceutical products and biologicals. The Bond issued by Eli Lilly ( United States ) , in USD, with the ISIN code US532457BC13, pays a coupon of 5.95% per year. The coupons are paid 2 times per year and the Bond maturity is 11/15/2037 The Bond issued by Eli Lilly ( United States ) , in USD, with the ISIN code US532457BC13, was rated Aa3 ( High grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by Eli Lilly ( United States ) , in USD, with the ISIN code US532457BC13, was rated A+ ( Upper medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||||||||||||||||||||
| |||||||||||||||||||||||||